A Prospective Study of Clinical Outcomes for the Pathwork Tissue of Origin Test

A Prospective Study of Clinical Outcomes for the Pathwork® Tissue of Origin Test

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01649453

Enrollment

Registered

2012-07-25

Start date

2012-05-31

Completion date

2013-02-28

Last updated

2013-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasm Metastasis

Keywords

Neoplasms, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes

Brief summary

The study prospectively assesses the change in cancer-specific clinical decisions and outcomes before and after physicians received results from the Pathwork® Tissue of Origin (TOO) Test for patients whose primary site of cancer origin is uncertain.

Interventions

DEVICEPathwork® Tissue of Origin Test

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* their physician ordered or intends to order a Pathwork® TOO Test between May 2012 and December 2013 * the patient is ≥ 18 years of age * the patient has given informed consent (online or verbal) * the patient is able to understand English.

Design outcomes

Primary

Measure	Time frame
Survival	2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026